BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fleseriu M. Pituitary Disorders and COVID-19, Reimagining Care: The Pandemic A Year and Counting. Front Endocrinol (Lausanne) 2021;12:656025. [PMID: 33776943 DOI: 10.3389/fendo.2021.656025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Fleseriu M, Biller BMK. Treatment of Cushing's syndrome with osilodrostat: practical applications of recent studies with case examples. Pituitary 2022. [PMID: 36002784 DOI: 10.1007/s11102-022-01268-2] [Reference Citation Analysis]
2 Popovic B, Radovanovic Spurnic A, Velickovic J, Plavsic A, Jecmenica-lukic M, Glisic T, Ilic D, Jeremic D, Vratonjic J, Samardzic V, Gluvic Z, Adzic-vukicevic T. Successful Immunomodulatory Treatment of COVID-19 in a Patient With Severe ACTH-Dependent Cushing’s Syndrome: A Case Report and Review of Literature. Front Endocrinol 2022;13:889928. [DOI: 10.3389/fendo.2022.889928] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Al-Salihi MM, Rahman MM, Al-Jebur MS, Rahman S, Lozada-Martinez ID, Rahman R, Moscote-Salazar LR. Optic neuritis concomitant with pituitary macroadenoma in a patient with active COVID-19 infection: A case report. Int J Surg Open 2021;35:100390. [PMID: 34568623 DOI: 10.1016/j.ijso.2021.100390] [Reference Citation Analysis]
4 Frara S, Loli P, Allora A, Santini C, di Filippo L, Mortini P, Fleseriu M, Giustina A. COVID-19 and hypopituitarism. Rev Endocr Metab Disord 2021. [PMID: 34387832 DOI: 10.1007/s11154-021-09672-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]